Bringing together the best of research and industry to overcome one of the biggest threats facing humanity.
Ineos Oxford Institute for antimicrobial research
Loading...
NEWS: New type of inhibitor could help tackle resistance against ‘last-resort’ antibiotics
Read about this study from @ineosoxford.bsky.social
IOI DPhil student Maria Nieto-Rosado is investigating how drug-resistant Klebsiella pneumoniae survive on surfaces like medical equipment and furniture in hospitals in LMIC countries .
Her PhD research aims to update global infection prevention guidelines.
Read more👉https://ow.ly/zzWi50Z9eV5
Researchers from Ineos Oxford Institute for antimicrobial research (IOI) have discovered that cephalosporins, a widely used class of antibiotics, can block a key enzyme that SARS-CoV-2 needs to replicate - 120 compounds were investigated.
👉Read more: https://ow.ly/xGMm50Z73To
Researchers from the IOI and Oxford AMR Network published four new studies related to antibiotic drug discovery in May, including investigations into the enzymes behind antimicrobial resistance, and the inhibitor drugs that stop them.
Find out more👉https://www.ineosoxford.ox.ac.uk/research
At our Early Career Researcher conference 2026, PhD student Alyaa Al-Tabtabai from King's College London shared her research on hydrogen sulphide gas and cold plasma as novel delivery systems for treating topical fungal infections.
👉Watch her talk: https://youtu.be/6Ac6nApwna0?si=3GySBu7ygyQzgZmk
At our Early Career Researcher conference 2026, Sid Mookerjee from Brighton and Sussex Medical School shared insights into how AI and digital tools are being developed to optimise how we monitor and treat infections in real-time.
👉 Watch the full talk: https://ow.ly/8oKf50YT7ln
